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Whole genome expression profiles are widely used to discover molecular subtypes of diseases. A remaining challenge is to
identify the correspondence or commonality of subtypes found in multiple, independent data sets generated on various
platforms. While model-based supervised learning is often used to make these connections, the models can be biased to the
training data set and thus miss inherent, relevant substructure in the test data. Here we describe an unsupervised subclass
mapping method (SubMap), which reveals common subtypes between independent data sets. The subtypes within a data set
can be determined by unsupervised clustering or given by predetermined phenotypes before applying SubMap. We define
a measure of correspondence for subtypes and evaluate its significance building on our previous work on gene set enrichment
analysis. The strength of the SubMap method is that it does not impose the structure of one data set upon another, but rather
uses a bi-directional approach to highlight the common substructures in both. We show how this method can reveal the
correspondence between several cancer-related data sets. Notably, it identifies common subtypes of breast cancer associated
with estrogen receptor status, and a subgroup of lymphoma patients who share similar survival patterns, thus improving the
accuracy of a clinical outcome predictor.
Citation: Hoshida Y, Brunet J-P, Tamayo P, Golub TR, Mesirov JP (2007) Subclass Mapping: Identifying Common Subtypes in Independent Disease
Data Sets. PLoS ONE 2(11): e1195. doi:10.1371/journal.pone.0001195
INTRODUCTION
DNA microarray-based whole genome expression profiling is
subject to poor reproducibility of discovered molecular disease
subtypes and can lead to biomarkers that do not generalize [1].
This problem arises from various technical and biological sources
including platform differences [2], and has been a major obstacle
to moving microarrays into the clinic as a tool to uncover as yet
unrecognized disease subtypes.
Comparison and integration of the molecular disease subtypes,
independently defined in different data sets, has been a highly
challenging problem. Subtypes are often based on subtle
differences in gene expression, which can be dominated by the
measurement variation between different experiments and/or
platforms. A widely used method to connect such independent
data sets, supervised learning, does not completely solve this
problem. Subtype models depend on one particular ‘‘training’’
data set with its own platform-specific data structure. This
structure may not be present in new ‘‘test’’ data sets.
Here we describe subclass mapping (SubMap), an unsupervised
methodthat revealscommon subtypesobserved inindependent data
setswithoutrelyingon,orbeing biasedby, one model dataset.Bybi-
directionally evaluating association of predetermined subtypes
between independent data sets, our method identifies more reliable
molecular disease subtypes and subpopulations of cohorts that share
similar clinical behavior. These results indicate the great potential of
this method to maximize the use of the vast amount of accumulating
genomics data and to improve current clinical practice through the
development of better diagnostics and therapeutics.
RESULTS
Overview of Subclass mapping (SubMap)
SubMapisanunsupervisedmethod,whichestimatesthesignificance
of an association between subclasses observed in two independent
data sets. The subclass labels are predetermined as manually
assigned phenotypes or by clustering prior to the application of the
SubMap algorithm (i.e., the SubMap algorithm does not assign a de
novo class label to each sample). Because the subclass correspondence
is evaluated for all pairs of subclasses, one subclass drawn from each
data set, the number of subclasses or subtypes in the two data sets
does not need to be the same or even similar.
The mapping information obtained by SubMap can be used to
reveal general subclasses common to both data sets and thus
expose the likelihood that they share the same or similar
underlying biological property. Details of our approach are
described in the Materials and Methods section and Figure 1.
Here we review the three key steps in the SubMap method:
Step 1: Measure similarity between subclasses We start
with two independent data sets, A and B, with candidate subclasses
independently determined in both. For simplicity, suppose we
have two candidate subclasses in each data set: A1 and A2 in data
set A; B1 and B2 in data set B. We define a set of marker genes,
marker(A1) for subclass A1, and similarly for A2, using any suitable
subclass discrimination metric. Using the same metric, genes in
data set B are rank-ordered according to their correlation with B1
vs. B2 to yield a gene list, ranking(B1). Association between A1 and
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marker(A1) in the up-regulated end of the list ranking(B1) using
Gene Set Enrichment Analysis (GSEA) as described in [3]. The
latter provides both an enrichment score (ES) and a corresponding
nominal p-value by means of an empirical permutation test. We
repeat this process, interchanging the roles of A1 and B1, to
compute a nominal p-value for the enrichment of marker(B1) in
ranking(A1). We can generalize this process straightforwardly when
there are more than two candidate subclasses in either data set and
compute a pair of nominal p-values for every possible pair-wise
combination of subclasses. Thus if there are nA subclasses in A and
nB subclasses in B, then we have mutual association information
for each of the nA*nB pairs of candidate subclasses from the two
independent data sets.
Step 2: Estimate significance of association between
subclasses To summarize and estimate the significance of the
mutual association information, i.e., the pair of nominal p-values for
the ES, we use the Fisher inverse chi-square statistic, F [4]. To
estimate a nominal p-value for F, we generate an appropriate null
distribution by randomly picking ES scores from the null
distributions corresponding to each direction of the enrichment
analysis (e.g., marker(A1) in ranking(B1) and marker(B1) in ranking(A1))
and generating the corresponding Fisher inverse chi-square statistic.
Step 3: Construct and cluster subclass association
matrix We use a Bonferonni adjustment to account for multiple
hypotheses testing, and summarize the adjusted p-values in a matrix
called the subclass association matrix (SA matrix). Two-way
clustering of this matrix reveals general subclasses common to
these data sets.
Weapplied our method tofourpairs of publicly available data sets
(Table 1). We first validated our method by correctly recovering
expected associationsofsubclassesusing apairofdatasetscomprised
ofmultipletissue types (Example1). Nextwe analyzed diffuselarge B
cell lymphoma (DLBCL) data sets to show the superiority of our
method to standard supervised prediction methods (Example 2). We
then applied our method to breast cancer data sets to identify
a common subtype we found to be associated with the estrogen
receptor status (Example 3). The final example shows that our
method has the potential to improve the performance of molecular
marker-based patient outcome prediction (Example 4). We note that
all of these analyses were performed on data sets acquired on a wide
variety of DNA microarray platforms.
Example 1. Multiple tissue types
For a straightforward validation of subclass mapping, we used two
data sets of multiple normal tissue types acquired on two different
generations of the Affymetrix GeneChip oligonucleotide micro-
array platform, Multi-A [5] and Multi-B [6]. This represents the
case where subtypes are determined by ancillary phenotype
information rather than ‘‘discovered’’ by clustering. Both data sets
include four distinct tissue types, i.e., breast, prostate, lung, and
colon. The only cross-dataset pairs of subtypes showing significant
association corresponded to the same tissue type (Figure 2a).
In actual biological or clinical data sets that nominally include
the same or similar samples, the entire range of sample diversity in
one data set may not be represented in the other data sets, i.e.,
a subclass in one data set may not be represented in others. To
assess whether such a situation would lead to false positive
associations, we removed the samples corresponding to one tissue
type in Multi-B and re-ran SubMap with the Multi-A (Figure 2b).
Importantly, only subsets of the same tissue type were significantly
associated, and there were no false positive calls.
We next investigated whether the choice of the number of
marker genes to be mapped might affect the result of SubMap.
The number of strongly differentially expressed genes for cross-
dataset subclass pairs might differ. Since we are using the same
number of marker genes for all comparisons we sought to confirm
that the enrichment score was robust. We believed this would be
Figure 1. Subclass mapping (SubMap) methodology. Two independent
data sets, A and B, are clustered separately, compared and integrated.
(a)CandidatesubclassesaredefinedbyclusteringAandB(predetermined
phenotype can also be used). Marker genes of each candidate subclass in
A( A i) are selected, and mapped onto a gene list ranked according to their
differential expression with respect to a subclass of B (Bj). Their over-
representationatthetopoftherankingisevaluatedusingtheenrichment
score (ESAiBj), and significance is assessed as a nominal p-value, pAiBj,b y
randomly permuting sample class labels in B. This process is repeated by
interchanging the role of A and B to compute ESBjAi and pBjAi. (b) Mutual
enrichment information, pAiBj and pBjAi, are combined using the Fisher
inverse chi-square statistic, Fij. Its significance is estimated based on a null
distribution for the Fij generated by randomly picking the nominal-p from
corresponding null distributions for ESAiBj and ESBjAi.A f t e rm u l t i p l e
hypothesis testing (MHT) correction, p-values for Fij are summarizedinthe
subclass association (SA) matrix. Clustering of the SA matrix reveals
subclasses common to A and B.
doi:10.1371/journal.pone.0001195.g001
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effect of using 20, 50, and 200 ranked marker genes from a list of
differentially expressed genes, as they represent the number of
markers commonly used in classification and prediction studies for
microarray data, as well as the level at which we might expect to
begin to see noise. The resulting observed significance calls were
quite stable for pairs of same tissue type irrespective of the number
of the marker genes used (Figure S1).
Example 2. Diffuse large B cell lymphoma:
comparison with other methods
Here we show the superiority of SubMap in directly highlighting
all three of the corresponding, common subtypes in two
independent Diffuse Large B-Cell Lymphoma (DLBCL) data sets.
We first compare with our previous work in [7] where two of the
three common subtypes could only be associated after removing
the third. Importantly, we also show how supervised approaches,
building a model from one data set to identify the subtypes in the
other, also fail to identify all three shared subtypes.
We analyzed two DLBCL data sets, DLBCL-A [7] and DLBCL-
B [8]. The data sets were generated using one-channel oligonucle-
otide microarrays and 2-channel custom cDNA microarrays,
respectively. In previous work we found three robust subtypes in
both DLBCL-A and DLBCL-B using resampling-based multiple
clustering trials and three different clustering algorithms [7,9]. The
three clustered subtypes were designated as ‘‘oxidative phosphory-
lation (OxPhos)’’, ‘‘B-cell response (BCR)’’, and ‘‘host response
(HR)’’ according to relevant molecular mechanisms.
In this precedent analysis, we associated these subtypes between
the data sets by assessing the overlap of each subtype’s marker
genes in both data sets one-by-one using the Fisher test for a 262
table. However, unlike SubMap, this approach is highly sensitive
to the criteria for marker gene selection and the total number of
genes common to both platforms. Notably, initially only the HR
clusters from the two datasets showed a significant association, and
only after their removal could we identify the significant
association for the OxPhos and BCR subtypes [7]. However,
our SubMap method immediately and automatically recovered
the three-subclass structure common to both data sets without
removing any samples (Figure 3). This is likely due to the method’s
ability to capture subtle, but reproducible, subclass associations by
incorporating bi-directional marker gene enrichment information.
Next we compared SubMap with supervised methods for their
ability to identify similar subtypes from distinct data sets using
DLBCL-A and DLBCL-B. Supervised learning methods are widely
used to associate two independent data sets; the model of the
subtype is defined in a ‘‘training’’ data set, and assessed in a ‘‘test’’
data set. We employed two standard supervised methods, k-nearest
neighbors (k=7, and 10 marker genes) and support vector
machines (using all genes in common) and interchanged the roles
of the two sets as train and test (details are described in the
Materials and Methods). Both the k-NN and SVM predictors failed
to reliably predict all three DLBCL subtypes. When the DLBCL-B
was used to train the model, only the HR clusters were associated
by prediction (accuracy$90%). When the DLBCL-A was used to
Table 1. Data sets
..................................................................................................................................................
Group Data set No. of samples
Type of
microarray Platform description GEO platform ID reference
1. Multiple tissue types (breast, lung, prostate, colon) Multi-A 103 1-channel HG-U95A* GPL91 [5], (a)
Multi-B 32 1-channel HuGeneFL, Hu35k-A* GPL80, 98 [6], (a)
2. Diffuse large B cell lymphoma DLBCL-A 141 1-channel HG-U133A* GPL96 [7], (a)
DLBCL-B 180 2-channel Lymphochip N/A [8], (b)
3. Breast cancer Breast-A 98 2-channel Hu25K** N/A [11], (c)
Breast-B 49 1-channel HuGeneFL* GPL80 [12], (a)
4. Diffuse large B cell lymphoma (with survival data) DLBCL-C 58 1-channel HuGeneFL* GPL80 [14], (a)
DLBCL-D 129 1-channel HG-U133A* GPL96 [7], (a)
1-channel: sample RNA is labeled by single dye, 2-channel: sample and reference RNA are labeled by different
dyes and competitively hybridized.
GEO: National Center for Biotechnology Information’s Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/),
GPL and GSE are accession number for miceroarray platform and gene set, respectively, depositted in th GEO.
(a) http://www.broad.mit.edu/cgi-bin/cancer/datasets.cgix
(b) http://llmpp.nih.gov/DLBCL/
(c) http://www.rii.com/publications/default.htm
Microarrays manufactured by *Affymetrix (Santa Clara, CA) or ** Agilent Technologies (Palo Alto, CA)
doi:10.1371/journal.pone.0001195.t001
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Figure 2. Example 1: Multiple tissue types. (a) SubMap was applied to
two data sets, Multi-A and Multi-B, containing multiple tissue types:
breast (Br), prostate (Pr), lung (Lu), and colon (Co). Bonferroni-corrected
p-values for breast, prostate, lung, and colon tissues were 0.002, 0.002,
0.002, and 0.002, respectively. (b) Each tissue type in Multi-B was
removed before applying SubMap. Only subsets of the same tissue type
were significantly associated (Bonferoni-corrected p,0.05). The p-
values for ‘‘Multi-A-Br and Multi-B-Lu (left-upper)’’, ‘‘Multi-A-Lu and
Multi-B-Br (left-bottom)’’, and ‘‘Multi-A-Co and Multi-B-Br (right-bot-
tom)’’ are 0.330, 0.547, and 0.517, respectively
doi:10.1371/journal.pone.0001195.g002
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classifier (accuracy$90%), and none by the k-NN predictor (all
accuracies#51%). (See Table S1 for full results). In addition, we
tested a recently reported method, called clusterRepro [10]. This
method assumes a model of subclassification in one data set, and
evaluates it in another data set. Again we only observed significant
reproducibility (accuracy$90%) for the HR cluster, in this case
when DLBCL-A was used as the model set (Table S2).
In this example we see the difficulty of identifying common
subclasses and how SubMap outperforms four other approaches.
Example 3. Breast cancer: estrogen receptor status
We next compared SubMap method with another more
straightforward approach, i.e., to merge the two independent
data sets into a single data set, and and then to run clustering to
find subtypes observed in the combined data. To this end, we
employed two breast cancer data sets, Breast-A [11] and Breast-B
[12] generated using one-channel oligonucleotide and two-
channel microarrays, respectively. Hierarchical clustering, after
simply merging the two data sets, only revealed the dominant
experiment-of-origin-specific structure despite several attempts of
normalization (Figure S2), whereas SubMap identified common
subtypes associated with a key molecular determinant of a disease
as described below.
Using hierarchical clustering as described in Materials and
Methods, we identified three (A1,A 2, and A3) and four (B1,B 2,B 3,
and B4) candidate subclasses in Breast-A and Breast-B, respectively
(Figure 4a) as described in the Materials and Methods section.
SubMap revealed the common subtypes as two sets of significant
associations, ‘‘A1 < A2 and B1 < B3‘‘ and ‘‘A3 and B2 < B4‘‘
(Figure 4b). We note the dominant substructure (i.e., first splitting
in the dendrogram in Figure 4a) in Breast-B is B1 < B2 and B3 <
B4. Thus, the subgrouping of samples from Breast-B that associate
with Breast-A might not be evident by looking at Breast-B alone.
Both data sets have immunohistochemistry data of estrogen
receptor (ER) status, which is known to play important role in
breast cancer biology, e.g., BRCA1 mutation, lymphocytic
infiltration, and early occurrence of distant metastasis [11,13]. In
fact, this was the only sample-phenotype information common to
both data sets. Thus, we sought to evaluate if the common
subtypes obtained by our method captured this ancillary
phenotypic information. We found that the common subtypes
defined by SubMap were significantly associated with the ER
status in each data set (Breast-A: ER was positive in 50/61 cases of
A1 < A2, and 3/36 cases of A3. p=4.2e-13. Breast-B: ER was
positive in 18/19 cases of B1 < B3, and 7/23 cases of B2 < B4.
p=8.0e-7. Fisher’s exact test). This result leads us to speculate that
ER status may indeed be a significant factor in determining the
subclasses and subclass associations.
To investigate this hypothesis further, we evaluated the
expression status of ER signaling-related genes in the common
subtypes to confirm that the subtypes are relevant to the biology of
ER signaling. In both input data sets, we ranked genes by the extent
of their up-regulation in the subtypes with more ER positive cases
(A1 < A2 and B1 < B3), and evaluated the over-representation of
the ER-related gene set (Table S3) using Gene Set Enrichment
Analysis [3]. The ER-related gene set was significantly over-
expressed with p-values of 0.033 and 0.010 in A1 < A2 within
Breast-A and B1 < B3 within Breast-B, respectively.
The association between A1 and B3 was not statistically
significant (Figure 4b). In fact, the number of cases with lymph
node metastasis in B1 (8/12, 67%) is larger than that of B3 (2/7,
29%). Although this difference is not statistically significant
(p=0.170, Fisher’s exact test), this might suggest the existence of
some biological heterogeneity among the ER-positive subclasses,
and cause such ‘‘step-like’’ shape.
Example 4. Diffuse large B-cell lymphoma: patient
survival
In this final example, we applied SubMap to see if identifying the
corresponding subtypes in two diffuse large B-cell lymphoma data
sets would enable us to distinguish subpopulations relevant to patient
survival. We analyzed two independent DLBCL data sets, DLBCL-
Figure 3. Example 2: Common subtypes of Diffuse Large B-cell
Lymphoma (DLBCL). SubMap was applied for three subclasses of
DLBCL pre-determined in DLBCL-A and DLBCL-B data sets. Bonferroni-
corrected p-values for ‘‘oxidative phosphorylation (OxPhos)’’, ‘‘B-cell
response (BCR)’’, and ‘‘host response (HR)’’ subtypes were 0.008, 0.001,
and 0.001, respectively. The association for the pair of DLBCL-A-BCR and
DLBCL-B-OxPhos was not significant (p=0.362).
doi:10.1371/journal.pone.0001195.g003
Figure 4. Example 3: Common subtypes of breast cancer associated
with estrogen receptor (ER) status. (a) Candidate subclass labels were
assigned using hierarchical clustering in Breast-A and Breast-B data sets
independently. (b) Subclass association (SA) matrix for Breast-A and
Breast-B. Bonferroni-corrected p-values for the combinations of ‘‘A1 and
B2’’, ‘‘A1 and B4‘‘, ‘‘A2 and B1’’, ‘‘A3 and B1’’, and ‘‘A3 and B3’’ were 0.070,
0.002, 0.023, 0.001, and 0.055, respectively (FDR-corrected p-values of
0.014, 0.001, 0.008, 0.001, and 0.014, respectively). *: ER status is missing
for one case.
doi:10.1371/journal.pone.0001195.g004
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samples in DLBCL-A from Example 2 for which survival
information was available. DLBCL-C is a third independent data
set. These data sets were generated using different generations of the
Affymetrix GeneChip oligonucleotide microarray.
Using hierarchical clustering, four candidate subclasses were
defined in each data set (C1,C 2,C 3, and C4 in DLBCL-C, and D1,
D2,D 3, and D4 in DLBCL-D). There was no statistically
significant difference in the survival curves among these subclasses
(data not shown). SubMap identified two significantly correspond-
ing pairs of subclasses between these two data sets, ‘‘C3 and D2’’
and ‘‘C4, and D3’’ (Figure 5a).
We next sought to determine whether we could improve the
survival distinction between samples by restricting our consideration
to the corresponding subclasses. Based on the sample labeling of
poor prognosis in DLBCL-C defined in [14], we built a survival
predictive model using a supervised learning method, k-nearest
neighbor algorithm (k=3, and 10 marker genes), and tested it in
DLBCL-D (Figure 5b). When the model was built using only
matched subclasses, C3 < C4 (n=25), and tested in their counter-
parts, D2 < D3 (n=61), the predictive model yielded better
separation of survival than a model built using all of the samples
(Figure 5b) in spite of having many fewer, nearly half, the number of
samples to build and test the predictor. On the other hand, the
predictor trained using unmatched subclasses, C1 < C2 (n=33) did
not work on D1 < D4 (n=68) This suggests that the predictive
survival signature common to both of the data sets is carried by the
‘‘corresponding’’ cases, which our method identified.
DISCUSSION
Genomic profiling is a powerful approach to discovering molecular
disease subtypes. However, the uncovered subtypes may also reflect
idiosyncrasies, technical variation, representational and measure-
ment biases that limit the ability of the model and results to
generalizetootherstudiesorplatforms.Inthispaper,wehaveshown
how SubMap can address these issues and be an effective approach
to recognizing subtypes across different data sets.
In the four examples presented above the method clearly
outperforms several more traditional, alternative approaches such
as, i) using supervised models (e.g., k-NN and SVM) to learn the
subclasses obtained in one of the datasets and then predicting the
subclass membership of the samples in the second set, ii) merging the
two data sets and clustering samples to search for common subtypes,
iii) associating the subtypes between the data sets by assessing the
overlap of each subtype’s marker genes in both data sets, or iv)
creating an explicit model of subclassification in one data set, and
evaluating it in another data set (e.g., clusterRepro). All of these
alternative methods have serious limitations and do not always
produce reproducible results. While two different datasets may claim
to represent the same biological phenotype, they often contain differ-
ent molecular subtypes or biased representations and samplings with
different dynamic ranges, measurement biases, probe efficiencies etc.
Thesedifferencesviolatethecommonunderlyingassumption,ofthese
other approaches-that two instances of the data, such as the train and
test set, are samplings from the same probability distribution.
SubMap associates the subclasses between datasets by using
a more abstract, higher-level similarity measure (i.e., the
Figure 5. Example 4: Survival prediction in Diffuse Large B-cell lymphoma (DLBCL) data sets. (a) Subclass association (SA) matrix for the
comparison between DLBCL-C and DLBCL-D data sets. Bonferroni-corrected p-values for the pairs of ‘‘C3 and D2’’ and ‘‘C4 and D3’’ were 0.002 and
0.002, respectively, (b) Survival prediction models were built using DLBCL-C and applied to DLBCL-D. Kaplan-Meier survival curves for the predicted
groups in DLBCL-D are shown. Left: Prediction model was trained using all cases in DLBCL-C (n=58), and tested on all cases in DLBCL-D (n=129).
Middle: Survival prediction using only cases from ‘‘matched’’ subclasses. Model was trained using C3 < C4 samples (n=25) and tested in D2 < D3
(n=61). The survival separation was better than that in the left panel in spite of having fewer samples. Right: survival prediction using only cases from
‘‘unmatched’’ subclasses. Model was trained using C1 < C2 (n=33) and tested in D1 < D4 (n=68). The numbers of events were 61, 22, and 39 for all
(D1 < D2 < D3 < D4), ‘‘matched’’ (D2 < D3), and ‘‘unmatched’’ (D1 < D4) patients, respectively. p-values were calculated using the log-rank test. DFS:
disease free survival.
doi:10.1371/journal.pone.0001195.g005
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the concordant collective behavior of groups of genes rather than
specific gene expression values, and does not rely on one particular
data set to define a ‘‘model’’ like supervised learning methods. The
result of this approach, which concurrently and bi-directionally
evaluates similarity by treating the two input data sets equally within
a self-contained unit, is that SubMap is able to provide solutions to
the mapping problem that are more robust, more generalizable and
more tolerant of the platform idiosyncrasies and biases.
SubMap performs marker gene selection multiple times. For
example, in the case where data set A and B have 3 and 4
subclasses, respectively, it performs maker gene selection 7 times, 3
times in data set A and 4 times in data set B. We cannot assume
the same number of statistically ‘‘significant’’ marker genes for all
of them, and to compute the significance for each round of marker
selection by, e.g., permutation testing is highly computationally
intensive. The GSEA enrichment score (ES) is weighted by the
correlation between gene expression signals and the subclass.
Therefore, genes having small correlation with phenotype (i.e., less
significant genes) show negligible contribution in the computation
of the ES. For this reason, there is no need to set significance
thresholds to select the marker genes. The fixed number of marker
gene set only needs to include sufficient significant marker genes to
produce a robust ES (see Figure S1).
Another important and useful property of SubMap is that it
helps to identify an appropriate level of subclass granularity to
select the best overall concordance. Typically in unsupervised
clustering, the depth of splitting of the clustering solution is
somewhat arbitrary. Even when a model selection method is used,
there is the possibility of over-fitting to a dataset structure that
represents batch effects or platform idiosyncrasies. As a conse-
quence, a dominant structure in one data set might not necessarily
show the best concordance with the other data set. A concrete
example of this was shown in Example 3, where the second
dominant splitting in Breast-B, rather than the first, showed the
best concordance with Breast-A. The clustering of the subclass
association matrix gives an indication of which candidate
subclasses show the best concordance between the data sets.
The use of more robust and generalized subclasses enables the
better utilization of microarray data and the construction of better
classification models. For example, the possibility of mapping the
corresponding classes across a large collection of cross-platform or
cross-laboratory datasets provides a method to increases the
number of available samples related to a given phenotype. This
translates to a better signal to noise ratio and thus improves the
selection of biomarkers and the training of more accurate, robust,
and generalizable supervised classifiers. Moreover, SubMap can
provide a more precise stratification of the data for the application
of predictive models. In Example 4, our method identified
subpopulations in two independent data sets, where a clinical
outcome predictor is more accurate than one modeled by all the
samples. This additional resolution might help explain why an
outcome predictor works only on a subset of the population. The
integration and utilization of multiple datasets, representing
a wider span of the biological space of interest, can both increase
the accuracy of models as described above and provide models
that are more interpretable, realistic, and biologically meaningful.
The ability of SubMap to find common subtypes across data sets
is, of course, dependent on the representation of the subtypes in
those data sets, and the quality and granularity of their labeling.
This is true whether the samples are labeled manually by, for
example, a pathologist, or computationally by clustering. At
a coarser granularity (i.e., smaller number of larger candidate
subclasses), a biological subclass of interest might be missed. On
the other hand, a finer granularity (i.e., larger number of smaller
candidate subclasses) could yield an unbalanced comparison in
selectingthemarkergenes.Inaddition,toofineaclasssplittingmight
yield multiple similar candidate subclasses, which might cause
a failure to detect distinct marker genes resulting in lower sensitivity
in detecting subclass association. However, we note here that, aside
from the issue of increasing runtime, there is no ap r i o r ilimit on the
number of the candidate subclasses that can be associated as long as
they have robust corresponding marker genes.
SubMap is an exploratory method, and the optimal (or
biologically reasonable) number of the candidate subclasses would
depend on the particular data sets with complex trade-offs. One
possible approach is to define multiple possible candidate
subclassifications in each data set, and evaluate the subclass
association structure in all combinations of candidate subclassifica-
tions (Figure S4). To define an appropriate measure or statistic to
evaluate such a search for optimal candidate subclasses will require
further consideration and investigation.
In summary, SubMap is a method that provides more general
molecular subclass identification and correspondence among
a collection of microarray data sets. By allowing the integration
of multiple data sets measured on different platforms, from
different laboratories, it increases the possibility of extracting more
meaningful biological subclasses and their corresponding bio-
markers and classifiers. This has the potential to improve gene
expression-based clinical classifiers where robustness, generaliza-
tion, and reproducibility across platforms are paramount.
The entire methodology is implemented as the SubMap module
of the GenePattern software and is freely available from http://
www.broad.mit.edu/genepattern/.
MATERIALS AND METHODS
Data preprocessing
We started from data sets that were already normalized for their
respective study without any additional normalization procedure
to account for different platform derivation. For the signal
intensity data generated by one-channel oligonucleotide micro-
arrays, Affymetrix’s GeneChip, we applied a lower threshold of
20U and a upper threshold of 16,000U. For the log2 transformed
ratio data generated by cDNA microarrays, we first removed
genes whose values were missing in more than 5% of the samples,
and then imputed the missing values for the rest of the genes using
a k-nearest neighbor algorithm [15] (ImputeMissingValues.KNN,
in the GenePattern software package, http://www.broad.mit.edu/
genepattern/).
Before marker gene selection, we used following gene filtering.
For the oligonucleotide array data, only genes exhibiting at least 3-
fold differential expression and an absolute difference of at least
100 units across the samples in the experiment were included. For
the cDNA array data, only genes with an absolute log2 ratio
greater than one and whose difference in log2 ratio across all the
samples in the data set was greater than one were included.
Before applying the SubMap, each microarray probe ID was
converted into its corresponding HUGO gene symbol (http://
www.gene.ucl.ac.uk/nomenclature/), and multiple probe data
corresponding to a single gene symbol was averaged. The number
of genes remaining for our analyses of multiple tissue types,
DLBCL, breast cancer, and DLBCL (with survival data) data sets
were 5565, 661, 1213, and 3795, respectively.
Subclass mapping (SubMap)
The algorithm and pseudocode for SubMap is shown in Box S1.
We describe the algorithm in more detail below.
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an approach to evaluate the relationship between otherwise
determined subclass structures in independently generated data
sets. Thus, any clustering method can be used to generate
candidatesubclasslabels.Alternatively,biologically/clinicallyknown
phenotype information can be used as candidate subclass labels. For
the specific examples described in the results section, we chose to use
agglomerative hierarchical clustering to generate candidate subclass
labels(Figure 1a) [16].Weused thePearson correlation coefficient as
a distance metric and the average linkage method from the dChip
software (www.biostat.harvard.edu/complab/dchip). We deter-
mined subclass splitting by tracing from the root of the
dendrogram. A subclass that contained at least 10% of the samples
was considered as a possible candidate subclass. We set the
maximum number of the candidate subclasses as four. Any other
criteria could be used to define a candidate subclass.
ii) Similarity between candidate subclasses in each data
set: enrichment score (ES) Suppose data set A and B have nA
and nB candidate subclasses, respectively. First, we take the top 100
differentially expressed genes between a candidate subclass (CS)a n d
the rest of the candidate subclasses (nonCS) the data set A. Such
marker genes are identified for each candidate subclass in A. In data
set B, genes are ordered according to their differential expression
with respect to CS vs. nonCS. To evaluate differential gene expression
between CS and nonCS, any measure, e.g., t-statistic, can be used. In
this study, we used the signal-to-noise ratio (SNR), (mCS-mnonCS)/
(sCS+snonCS), where mi and si denote, respectively, the sample mean
and sample standard deviation within class CS or nonCS [17]. Thus,
every candidate subclass in A has a set of marker genes, and every
candidate subclass in B has a gene list ranked by differential
expression between the candidate subclass and the remaining
candidate subclasses in B. Alternatively, other methods for gene
selection and ranking such as neighborhood analysis [17],
Significance Analysis of Microarrays [18], and the false discovery
rate (FDR)-based approaches [19] can easily be used.
For every pair-wise combination of nA marker gene sets and nB
gene rankings, class similarity is measured by calculating a gene set
enrichment score (ES) and estimating its significance as previously
described in [3]. Briefly, in each ranked gene list for Bj (jM{1,…,nB}),
a marker gene set of a candidate subclass Ai (iM{1,…,nA}) is
identified, and its enrichment or over-representation at the top of the
list is measured by computing a ES (observed ESAiBj). The ES is
essentially a Kolmogorov-Smirnov score weighted by the SNR.
We recompute the ESAiBj for 1000 random assignments of the
subclass labels in Bj to generate a null distribution for ESAiBj.W es o r t
the resulting ES scores in the null distribution, and estimate the
significance of the observed ESAiBj from its rank in the list as
a nominal p-value (pAiBj). We repeat this process by interchanging
the role of the data sets A and B. Thus, we compute pAiBj and pBjAi.
iii) Significance of association between candidate
subclasses We next sought a summary statistic for pAiBj and
pBjAi in order to obtain combined mutual marker gene enrichment
information as a measure of similarity of subclasses in the two
input data sets. We use the Fisher inverse chi-square statistic, Fij=
-2(log(pAiBj )+log(pBjAi)) to summarize the two p-values (Figure 1b)
[4,20]. The significance of Fij is estimated as a one-sided nominal
p-value in a null distribution for Fij generated by randomly picking
one rank p-value from the null distribution for each of ESAiBj and
ESBjAi and evaluating their Fisher statistic 10,000 times.
iv) Subclass association (SA) matrix We now have nA*nB
nominal p-values for all Fij (iM{1,…,nA}, jM{1,…,nB}). To correct
for multiple hypothesis testing, a Bonferroni correction is applied.
Alternatively, for cases with a larger number of candidate
subclasses, we can estimate a FDR by multiplying each nominal
p-value by nA*nB and dividing by the rank of the nominal p-value.
Using these corrected p-values, we obtain a subclass association
(SA) matrix, which represents the global association structure of
the candidate subclasses in the two independent data sets. By
applying two-way clustering on the SA matrix (we used
hierarchical clustering), it becomes possible to evaluate whether
there are common subclasses that exist in both data sets.
Prediction analysis
For prediction analysis, we used k-nearest neighbor (k-NN) and
support vector machine (SVM) modules from the GenePattern
software. For k-NN, briefly, genes in the training data set were
rank-ordered by the SNR. Using the selected marker genes,
prediction was performed based upon a majority vote of the class
membership of its k nearest neighbors in the training set weighted
by the reciprocal of the cosine distance. The k and the number of
marker genes were chosen so as to minimize the leave-one-out
cross-validation (LOOCV) error rate in the training set.
In Example 4, the prediction models were built based on
LOOCV. Fractional use of each gene in the LOOCV models was
calculated, and top 5 most frequently used genes were used for
class prediction in the test data set (Figure S3).
Survival analysis
Kaplan-Meir analysis and the log-rank test were performed using
GenePattern SurvivalCurve and SurvivalDifference modules,
respectively.
SUPPORTING INFORMATION
Table S1
Found at: doi:10.1371/journal.pone.0001195.s001 (0.02 MB
XLS)
Table S2
Found at: doi:10.1371/journal.pone.0001195.s002 (0.02 MB
XLS)
Table S3
Found at: doi:10.1371/journal.pone.0001195.s003 (0.01 MB
XLS)
Figure S1 Effect of the number of marker genes on the result of
SubMap.
Found at: doi:10.1371/journal.pone.0001195.s004 (0.10 MB TIF)
Figure S2 Two breast cancer data sets, Breast-A and Breast-B,
are directly merged and clustered. (a) Each column was
normalized by subtracting the column mean and divided by the
column SD before clustering. (b) Gene expression data are
converted to their rank in each column, and clustering was
performed using the rank to compute the distance. Pearson
correlation and the average linkage method were used for the
hierarchical clustering.
Found at: doi:10.1371/journal.pone.0001195.s005 (0.08 MB TIF)
Figure S3 Genes used for the survival prediction in Example 4.
Leave-one-out cross-validation (LOOCV) is performed using C3
< C4 in DLBCL-C as described in the Method section. Bar
indicates fractional use of each gene in LOOCV models. Box
indicates top 5 most frequently used genes in LOOCV that is used
for prediction in D2 < D3 in DLBCL-D. Genes shown in red are
also included in a prediction model built using all samples.
Found at: doi:10.1371/journal.pone.0001195.s006 (0.05 MB TIF)
Figure S4 Effect of granularity of the candidate subclasses on
SubMap result. In Breast-A and Breast-B data sets in Example 3,
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subclasses) was defined as subclasses having at least 10% of the
cohort. Each subclass was labeled by ‘‘number of subclasses’’-
‘‘data set’’-‘‘subclass number’’. In Breast-A, we defined sets of two
(2-A1 and 2-A2) and three (3-A1, 3-A2, and 3-A3) candidate
subclasses. In Breast-B, we defined sets of two (2-B1 and 2-B2), four
(4-B1, 4-B2, 4-B3, and 4-B4), and six (6-B1, 6-B2, 6-B3, 6-B4, 6-B5,
and 6-B6) candidate subclasses. SubMap was performed on all
combinations of sets of the candidate subclasses. When the
coarsest granularity (i.e., the smallest number of candidate
subclasses) was assumed in Breast-B, we observed no significant
subclass association (left heatmaps). When finer granularity was
assumed for Breast-B (middle heatmaps), significant ‘‘two-class’’
correspondence started to appear, indicating the coarsest granu-
larity in Breast-B was not appropriate to find significant subclass
association. The finest granularity for Breast-A derived more
significant associations (middle bottom heatmap). When the finest
granularity was assumed in Breast-B, a small fraction of samples
(6-B6) showed no association with any subclasses in Breast-A (right
heatmaps), suggesting that this is too fine a granularity yielding
weaker marker genes and lower sensitivity to capture a counterpart
of 6-B6.
Found at: doi:10.1371/journal.pone.0001195.s007 (0.13 MB TIF)
Box S1 Algorithm to generate a SA matrix.
Found at: doi:10.1371/journal.pone.0001195.s008 (0.29 MB
DOC)
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